Eventide Asset Management - NEWLINK GENETICS CORP ownership

NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 92 filers reported holding NEWLINK GENETICS CORP in Q2 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of NEWLINK GENETICS CORP
ValueSharesWeighting
Q1 2015$11,801,000
+37.6%
215,7000.0%0.89%
-5.1%
Q4 2014$8,574,000
+85.6%
215,7000.0%0.94%
+45.1%
Q3 2014$4,620,000
-19.3%
215,7000.0%0.64%
-17.2%
Q2 2014$5,727,000
-6.5%
215,7000.0%0.78%
-18.1%
Q1 2014$6,126,000
+76.9%
215,700
+37.1%
0.95%
-10.9%
Q4 2013$3,462,000157,3001.07%
Other shareholders
NEWLINK GENETICS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 93,533$962,0001.69%
WALL STREET ASSOCIATES 108,900$1,119,0000.74%
NORTHWEST WEALTH MANAGEMENT, LLC 57,482$591,0000.60%
Orbimed Advisors 1,991,700$20,475,0000.26%
TFS CAPITAL LLC 92,041$946,0000.25%
Intrinsic Edge Capital Management LLC 40,000$411,0000.18%
SECOR Capital Advisors, LP 100,529$1,033,0000.13%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 176,077$1,810,0000.12%
Piermont Capital Management Inc. 41,400$426,0000.10%
Vident Investment Advisory, LLC 67,209$691,0000.08%
View complete list of NEWLINK GENETICS CORP shareholders